Section Arrow
ATRC.NASDAQ
- AtriCure
Quotes are at least 15-min delayed:2026/11/05 03:17 EST
Regular Hours
Last
 65.53
+5.12 (+8.48%)
Day High 
66.02 
Prev. Close
60.41 
1-M High
62.9999 
Volume 
1.34M 
Bid
--
Ask
--
Day Low
58 
Open
58.06 
1-M Low
51.63 
Market Cap 
3.07B 
Currency 美元 
P/E 287.67 
%Yield -- 
10-SMA 60.4 
20-SMA 58.22 
50-SMA 56.03 
52-W High 62.9999 
52-W Low 25.36 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.21/0.26
Enterprise Value
3.15B
Balance Sheet
Book Value Per Share
10.15
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
465.31M
Operating Revenue Per Share
7.48
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc40.35+6.26+18.36%42.65PE
MMEDMiniMed Group, Inc.19.29+0.44+2.33%-- 
BAXBaxter International26.5+1.01+3.96%-- 
AVTRAvantor15.65+0.06+0.38%31.18PE
WRBYWarby Parker21.29-0.65-2.96%365.67PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.